Retrograde flush perfusion with low-potassium solutions for improvement ofexperimental pulmonary preservation

Citation
T. Wittwer et al., Retrograde flush perfusion with low-potassium solutions for improvement ofexperimental pulmonary preservation, J HEART LUN, 19(10), 2000, pp. 976-983
Citations number
29
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
JOURNAL OF HEART AND LUNG TRANSPLANTATION
ISSN journal
10532498 → ACNP
Volume
19
Issue
10
Year of publication
2000
Pages
976 - 983
Database
ISI
SICI code
1053-2498(200010)19:10<976:RFPWLS>2.0.ZU;2-U
Abstract
Background: Optimal preservation of post-ischemic organ function is a conti nuing challenge in clinical lung transplantation. Retrograde instillation o f preservation solutions has the theoretic advantage of achieving homogeneo us distribution in the lung because of perfusing both the pulmonary and the bronchial circulation. So far, we have seen no experimental studies that i nclude stereologic analysis of intrapulmonary edema concerning the influenc e of retrograde preservation on post-ischemic lung function after preservat ion with Perfadex and Celsior, Methods: In an extracorporeal rat model, we perfused 8 lungs, each, using e ither antegrade or retrograde perfusion technique with Celsior (CEant/CEret ) and Perfadex (PERant/PERret). Results were compared with low-potassium Eu ro-Collins. Postischemic lungs were reventilated and reperfused mechanicall y. We continuously monitored relative oxygenation capacity (ROC), pulmonary artery pressure, flush time, and wet/dry ratio. Furthermore, we used stere ologic means to evaluate edema formation. Statistics comprised different an alysis of variance models. Results: Relative oxygen capacity of CEant-protected lungs was superior to that of PERant preservation (p = 0.05). Use of PERret resulted in significa ntly higher ROC as compared with PERant (p < 0.001) and was comparable to r esults obtained with CE-preservation, which was not further improved with r etrograde application. Conclusion: Celsior provides better lung preservation than does Perfadex wh en administered antegradely. Retrograde application of Perfadex results in significant functional improvement as compared with antegrade perfusion, wh ich reaches the standard of Celsior-protected organs. Additional in vivo ex periments in combination with ultrastructural analysis are warranted to fur ther evaluate retrograde delivery of preservation solutions, which could be used in clinical lung transplantation to further optimize current results.